Lori McPartlin

Lori McPartlin is an accomplished professional in the field of biotechnology with extensive experience in process development, tech transfer, and research. Currently serving as Senior Manager of Tech Transfer and Senior Scientist at TScan Therapeutics since February 2020, Lori has previously held senior scientist roles at Semma Therapeutics and led the development of innovative treatment platforms at OvaScience. With a strong academic foundation, including a PhD from Cornell University in Molecular and Integrative Physiology, Lori has contributed to pioneering projects such as the GnRH fertility vaccine and the first successful homologous in vitro fertilization in horses. Lori's early career includes significant roles in product development and research at various organizations, demonstrating a robust history of advancing therapeutic solutions and a commitment to scientific innovation.